Danaher Is Marginally Overvalued

I last reviewed Danaher (DHR) in this February 1, 2024 post at which time the Q4 and FY2023 results had just been released. Prior to this post, I published Danaher Consistently Generates Strong Free Cash Flow and Danaher - Current Weakness Is A Buying Opportunity following the release of Q2 and Q3 results, respectively. In [...]

By |July 24th, 2024|Equity Investing|Comments Off on Danaher Is Marginally Overvalued

Is Intuitive Surgical’s Lofty Valuation Warranted?

When I wrote my April 20, 2024 Intuitive Surgical (ISRG) post, shares were trading at ~$366. In that post, I note that it was my 15th largest holding when I completed my 2023 Year End FFJ Portfolio Review at which time shares were trading at ~$337. The appreciation in ISRG's share price coupled with some [...]

By |July 23rd, 2024|Equity Investing|Comments Off on Is Intuitive Surgical’s Lofty Valuation Warranted?

Blackstone Realizations Should Accelerate

I try to identify great companies that, for whatever reason, appear to have temporarily fallen out of favor with investors. When I last added to my Blackstone (BX) exposure on May 9, 2023 @ ~$81.65, I was of the opinion that BX's share price was temporarily depressed for no justifiable reason. In contrast, the share [...]

By |July 19th, 2024|Equity Investing|Comments Off on Blackstone Realizations Should Accelerate

BlackRock Valuation Is Not Compelling

When I last reviewed BlackRock (BLK) in this April 15 post, the most currently available financial information was for Q1 2024. I considered shares to be reasonably valued and disclosed the purchase of another 30 shares @ ~$770/share on April 12; this increased my BLK exposure to 160 shares in the FFJ Portfolio. In several [...]

By |July 16th, 2024|Equity Investing|Comments Off on BlackRock Valuation Is Not Compelling

Can Nike Overcome Its Challenges?

There is no disputing that Nike (NKE) has experienced its fair share of challenges in recent years. Soft demand for sportswear in key markets and an increasingly competitive industry has resulted in lacklustre top line growth. In FY2020 and FY2024, for example, NKE reported a decline in YoY sales growth. On the Q4 2024 earnings [...]

By |July 3rd, 2024|Equity Investing|Comments Off on Can Nike Overcome Its Challenges?

2024 Mid Year FFJ Portfolio Review

My underlying reason for performing this 2024 Mid Year FFJ Portfolio Review is to get a high level overview of all our investments. I manage a total of 19 accounts held at two discount brokers. Unless I perform these reviews, I can not easily determine what percentage of our total holdings is held in each [...]

By |July 1st, 2024|FFJ Portfolio Holdings|Comments Off on 2024 Mid Year FFJ Portfolio Review

FFJ Portfolio – June 2024

This FFJ Portfolio - June 2024 report recaps my investment activity during the month. In my June 11 FFJ Portfolio Adjustments Before Capital Gains Tax Changes Arrive, I disclose multiple changes to the FFJ Portfolio. After these changes, drawing a direct comparison with prior periods is of little value. I, therefore,  am no longer providing [...]

By |July 1st, 2024|FFJ Portfolio Holdings|Comments Off on FFJ Portfolio – June 2024
Go to Top